Paul D'Angio
Director/Board Member bij NEXIMMUNE, INC.
Vermogen: 6 244 $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Paul D'Angio
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 22 | |
| Public Company | Pharmaceuticals: Major | 14 | |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.
13
| Extinct | Biotechnology | 13 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Paul D'Angio via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Chairman Director/Board Member | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| NEURONETICS, INC. | Medical Specialties | Director/Board Member | |
| University of Notre Dame | College/University | Undergraduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| ACASTI PHARMA INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
PDS Operating Corp.
 PDS Operating Corp. BiotechnologyHealth Technology PDS Operating Corp. operates as a biopharmaceutical company. It develops immunotherapies for cancer and infectious disease. The firm’s versamune is capable of potent activation of immune cells without the side effects of traditional vaccines, efficiently delivering disease related antigen targets to the immune system and promoting antigen processing to present antigen appropriately to generate both strong prophylactic and therapeutic immune responses to disease. The company was founded by Frank K. Bedu-Addo and Gregory L. Conn and is headquartered in Princeton, NJ. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Founder | |
Afferent Pharmaceuticals, Inc.
 Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afferent Pharmaceuticals, Inc. develops selective drugs for the treatment of debilitating neurogenic disorders. It offers programs for respiratory, cardiovascular, chronic pain, biology, and clinical trials. The firm offers drugs for osteoarthritis pain, treatment-refractory chronic cough, and interstitial cystitis or bladder pain syndrome. The company was founded by Anthony P. Ford in December 2009 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member | |
Noble Life Sciences, Inc.
 Noble Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Noble Life Sciences, Inc. provides in vitro and in vivo preclinical drug development services. It specializes in personalized medicine and biomarker research and preclinical drug development. The company was founded by Kenneth C. Carter in 2010 and is headquartered in Sykesville, MD. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member | |
| COGENT BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| GSK PLC | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| American University | College/University | Graduate Degree Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Doctorate Degree | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
| University of Michigan | College/University | Masters Business Admin Undergraduate Degree | |
| University of Cape Town | College/University | Doctorate Degree | |
Pfizer Ltd.
 Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The State University of New York | College/University | Corporate Officer/Principal Doctorate Degree | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor | |
Karus Therapeutics Ltd.
 Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Investor | |
| Semorex, Inc. | Director/Board Member Director/Board Member | ||
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| NETSCIENTIFIC PLC | Medical Specialties | Chairman Chief Executive Officer | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor Consultant / Advisor Consultant / Advisor | |
| ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ZYVERSA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| CONTRAFECT CORPORATION | Biotechnology | Chairman Director/Board Member | |
| INSPIREMD, INC. | Medical Specialties | Chairman Director/Board Member | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Zephyr Ai, Inc.
 Zephyr Ai, Inc. Packaged SoftwareTechnology Services Zephyr Ai, Inc. is a healthcare technology company based in Dallas, TX. Zephyr Ai is committed to revolutionizing drug discovery and precision medicine through partnerships and proprietary data. The company curates the world's most comprehensive healthcare dataset and uses cutting-edge artificial intelligence algorithms to generate novel insights that support patients, providers, and ongoing research. The company was founded in 2020 by Grant Lovely VerStandig, Jeff Sherman, and Yisroel Brumer. David L. Morgan has been the CEO of the company since 2022. | Packaged Software | Director/Board Member Founder | |
| CERTARA, INC. | Packaged Software | Director/Board Member General Counsel | |
| COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
| APTINYX | Pharmaceuticals: Major | Director/Board Member | |
Convergence Pharmaceuticals Ltd.
 Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| PROKIDNEY CORP. | Biotechnology | Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 39 |
| Verenigd Koninkrijk | 7 |
| Israël | 4 |
| Frankrijk | 2 |
| Zuid-Afrika | 2 |
Sectoraal
| Health Technology | 34 |
| Consumer Services | 11 |
| Finance | 3 |
| Technology Services | 3 |
| Commercial Services | 2 |
Operationeel
| Director/Board Member | 249 |
| Corporate Officer/Principal | 105 |
| Independent Dir/Board Member | 90 |
| Chairman | 72 |
| Founder | 41 |
Sterkste connecties
| Insiders | |
|---|---|
| James Healy | 50 |
| Jerome Zeldis | 38 |
| Richard Sykes | 36 |
| Sol Barer | 32 |
| Liam Ratcliffe | 32 |
| Robert Spiegel | 30 |
| Rosemary Crane | 23 |
| Kamil Ali-Jackson | 21 |
| Ilian Iliev | 21 |
| Alan S. Roemer | 21 |
| Stephen Glover | 19 |
| Kenneth Carter | 18 |
| Grant Verstandig | 17 |
| Gregory Freitag | 16 |
| W. Middlekauff | 14 |
- Beurs
- Insiders
- Paul D'Angio
- Bedrijfsconnecties
